Redhill Biopharma Ltd Cash Flow Quality Index
Redhill Biopharma Ltd cash flow quality index. Redhill Biopharma Ltd (RDHL) has a Cash Flow Quality Index of -13.91x as of June 2023. Operating cash flow of $-10.59 Million is below net income of $761.00K, suggesting accrual-heavy earnings not yet converted to cash. See Redhill Biopharma Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Redhill Biopharma Ltd (2023–2023)
Cash flow quality index of Redhill Biopharma Ltd from 2023 to 2023. Historical Cash Flow Quality Index for Redhill Biopharma Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Redhill Biopharma Ltd (RDHL) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Redhill Biopharma Ltd Cash Flow Quality Index by Year (2023–2023)
Redhill Biopharma Ltd cash flow quality index by year from 2023 to 2023. Year-by-year earnings quality comparison for Redhill Biopharma Ltd. For the full cash flow conversion analysis, see RDHL cash flow metrics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.50x | $-35.82 Million | $23.92 Million | — |